Combination antifungal therapy

被引：401

作者：

Johnson, MD

MacDougall, C

Ostrosky-Zeichner, L

Perfect, JR

Rex, JH

机构：

[1] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA

[2] Duke Univ, Med Ctr, Dept Pharm, Durham, NC 27710 USA

[3] Campbell Univ, Sch Pharm, Buies Creek, NC 27506 USA

[4] Univ Texas, Houston Med Sch, Ctr Study Emerging Reemerging Pathogens, Dept Internal Med,Div Infect Dis, Houston, TX USA

[5] AstraZeneca, Macclesfield, Cheshire, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 03期

关键词：

D O I：

10.1128/AAC.48.3.693-715.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：693 / 715

页数：23

共 224 条

[1] A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients [J].

AbeleHorn, M ;

Kopp, A ;

Sternberg, U ;

Ohly, A ;

Dauber, A ;

Russwurm, W ;

Buchinger, W ;

Nagengast, O ;

Emmerling, P .

INFECTION, 1996, 24 (06) :426-432

[2] TREATMENT OF MURINE CRYPTOCOCCAL MENINGITIS WITH AN SCH-39304-AMPHOTERICIN-B COMBINATION [J].

ALBERT, MM ;

GRAYBILL, JR ;

RINALDI, MG .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1721-1725

[3] COMBINED THERAPY WITH FLUCONAZOLE AND FLUCYTOSINE IN MURINE CRYPTOCOCCAL MENINGITIS [J].

ALLENDOERFER, R ;

MARQUIS, AJ ;

RINALDI, MG ;

GRAYBILL, JR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :726-729

[4] In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :245-247

[5] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates [J].

Arikan, S ;

Lozano-Chiu, M ;

Paetznick, V ;

Rex, JH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :327-330

[6] THERAPY OF MURINE ASPERGILLOSIS WITH AMPHOTERICIN-B IN COMBINATION WITH RIFAMPIN OR 5-FLUOROCYTOSINE [J].

ARROYO, J ;

MEDOFF, G ;

KOBAYASHI, GS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 11 (01) :21-25

[7] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].

Ascioglu, S ;

Rex, JH ;

de Pauw, B ;

Bennett, JE ;

Bille, J ;

Crokaert, F ;

Denning, DW ;

Donnelly, JP ;

Edwards, JE ;

Erjavec, Z ;

Fiere, D ;

Lortholary, O ;

Maertens, J ;

Meis, JF ;

Patterson, TF ;

Ritter, J ;

Selleslag, D ;

Shah, PM ;

Stevens, DA ;

Walsh, TJ .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14

[8] Prophylaxis and treatment of fungal infections associated with haematological malignancies [J].

Ascioglu, S ;

de Pauw, BE ;

Meis, JFGM .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 15 (03) :159-168

[9] TREATMENT OF DISSEMINATED TORULOPSIS-GLABRATA INFECTION WITH DO870 AND AMPHOTERICIN-B [J].

ATKINSON, BA ;

BOCANEGRA, R ;

COLOMBO, AL ;

GRAYBILL, JR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1604-1607

[10] In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans [J].

Barchiesi, F ;

Di Francesco, LF ;

Compagnucci, P ;

Arzeni, D ;

Giacometti, A ;

Scalise, G .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :59-65

← 1 2 3 4 5 6 7 8 9 10 →